¤¢¤Ê¤¿¤Î¸µµ¤¤ò̤Íè¤Ë¤Ä¤Ê¤° WAKUNAGA

¤ï¤¯¤ï¤¯·ò¹¯¾ðÊó´Û

º£·î¤Î·ò¹¯¾ðÊó ¥Ð¥Ã¥¯¥Ê¥ó¥Ð¡¼

¤¹¤°¤Ç¤­¤ë¡ªÅüÇ¢ÉÂÂкö
¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡ ¡¡Tomohiro Miura¡Êͯ±ÊÀ½Ìô¡¡³Ø½Ñ¡¦±Ä¶ÈÌôÀ©Éô¡Ë


ÅüÇ¢ÉÂ¤Ï°å³Ø¤Î¿ÊÊâ¤Ë¤è¤Ã¤ÆÂ¿¤¯¤Î´µ¼Ô¤Ï¤½¤Î¾É¾õ¤ò¥³¥ó¥È¥í¡¼¥ë¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡£¤·¤«¤·¡¢Ìô¤À¤±¤Ç¤³¤Î¼À´µ¤ò¼£ÎŤ¹¤ë¤³¤È¤Ï¤Ç¤­¤Þ¤»¤ó¡£À¸³è½¬´·¤Î²þÁ±¤¬1ÈÖ¤ÎÂкö¤Ç¤¹¡£¤¹¤°¤Ç¤­¤ëÅüÇ¢ÉÂÂкö¡¢»Ï¤á¤Þ¤»¤ó¤«¡©



¢¡¡þÅüǢɤμïÎà

ÅüǢɤˤϡ¢·ìÅüÃͤò²¼¤²¤ë¥¤¥ó¥¹¥ê¥ó¤ÎʬÈ礬¾¯¤Ê¤¯¤Æ·ìÅüÃͤ¬¾å¤¬¤ë£±·¿ÅüÇ¢¤È¥¤¥ó¥¹¥ê¥ó¤ÏʬÈ礵¤ì¤Æ¤¤¤ë¤±¤ì¤É¡¢¥¤¥ó¥¹¥ê¥ó¤Î¸ú¤­¤¬°­¤¯¤Ê¤ê¡¢·ìÅüÃͤ¬¥³¥ó¥È¥í¡¼¥ë¤Ç¤­¤Ê¤¤2·¿ÅüǢɤÎ2¼ïÎब¸ºß¤·¤Þ¤¹¡£ÅüǢɤÎ9³ä¤¬2·¿ÅüǢɤȸÀ¤ï¤ì¤Æ¤¤¤Þ¤¹¡£

¢¡¡þ¥¤¥ó¥¹¥ê¥ó¤Î¸ú¤­¤¬°­¤¯¤Ê¤ëÍýͳ

Åüʬ¤ÏÀ¸¤­¤Æ¤¤¤¯¤¿¤á¤ËɬÍפʥ¨¥Í¥ë¥®¡¼¸»¤Ç¤¹¡£¤½¤ì¸Î¡¢ÈþÌ£¤·¤¯´¶¤¸¤ë¤è¤¦¤ËÂΤ¬¤Ç¤­¤Æ¤¤¤Þ¤¹¡£¤·¤«¤·¡¢²á¾ê¤ËÀݼ褷¤¿Åüʬ¤Ï»éËäȤ·¤ÆÃߤ¨¤é¤ì¡¢ÈîËþ¤Î¸¶°ø¤Ë¤Ê¤ê¤Þ¤¹¡£

¥¤¥ó¥¹¥ê¥ó¤Î¸ú¤­¤¬°­¤¯¤Ê¤ë¸¶°ø¤Î¿¤¯¤ÏÈîËþ¤Ç¤¹¡£ÈîËþ¤Ë¤Ê¤ë¤ÈÈîÂç²½¤·¤¿»éËÃÁÈ¿¥¤«¤é½Ð¤ë°­¶Ìʪ¼Á¤¬¥¤¥ó¥¹¥ê¥ó¤Î¸ú¤­¤ò¼ÙË⤷¤Æ¤·¤Þ¤¤¤Þ¤¹¡£°ìÊý¤Ç¡¢Àµ¾ï¤Ê»éËúÙ˦¤«¤é¤Ï¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó¤È¸Æ¤Ð¤ì¤ëÁ±¶Ìʪ¼Á¤¬Ê¬È礵¤ì¡¢¤³¤ÎÁ±¶Ìʪ¼Á¤Ï¥¤¥ó¥¹¥ê¥ó¤Î´¶¼õÀ­¤ò¹â¤áÅüǢɤÎȯ¾É¤òÍÞ¤¨¤Þ¤¹¡££±)

¤è¤Ã¤Æ¡¢2·¿ÅüǢɤò¼£ÎŤ¹¤ë¤¿¤á¤Ë¤ÏÀ¸³è½¬´·¤ò²þÁ±¤·¡¢ÈîËþ¤ò²ò¾Ã¤¹¤ëɬÍפ¬¤¢¤ê¤Þ¤¹¡£ ÆüËܿͤϲ¤ÊƿͤÈÈæ³Ó¤·¤Æ¥¤¥ó¥¹¥ê¥óʬÈçǽÎϤ¬Ä㤤¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤ë¤¿¤á¡¢ÈîËþ¤Ë»ê¤é¤Ê¤¤¿Í¤Ç¤âÃí°Õ¤¬É¬ÍפǤ¹¡£

¢¡¡þÅüǢɤòÊüÃÖ¤¹¤ë¤È

·ìÅüÃͤ¬¹â¤¤¤Þ¤Þ¤ÎÀ¸³è¤ò³¤±¤ë¤È¡¢·ì´É¤¬¤â¤í¤¯¤Ê¤ê¡¢¥Ü¥í¥Ü¥í¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤¤¤Þ¤¹¡£¤½¤·¤Æ¡¢Á´¿È¤Ë¥Í¥Ã¥È¥ï¡¼¥¯¤ò·ë¤ó¤Ç¤¤¤ë·ì´É¤È¿À·Ð¤¬¿¯¤µ¤ì¡¢Å¬Àµ¤Ê±ÉÍܤζ¡µë¤¬ÅÓÀ䤨¤ÆÁ´¿È¤Î¡´ï¤Ë¤µ¤Þ¤¶¤Þ¤Ê¾ã³²¤¬µ¯¤³¤Ã¤Æ¤­¤Þ¤¹¡£¡¡

¡¡ ¤Þ¤¿·ìÅüÃͤ¬¹â¤¤¾õÂÖ¤¬Â³¤¯¤ÈÌȱֵ¡Ç½¤Ë¤â±Æ¶Á¤òµÚ¤Ü¤·¤Þ¤¹¡£¹â·ìÅü¾õÂÖ¤¬Â³¤¯¤ÈÇò·ìµå¤È¸Æ¤Ð¤ì¤ëÌȱֺÙ˦¤Îµ¡Ç½¤¬Äã²¼¤·¤¿¤ê¡¢·ì´É¤¬¥Ü¥í¥Ü¥í¤Ë¤Ê¤ë¤³¤È¤Ç´¶À÷Éô°Ì¤ËÌȱֺÙ˦¤¬Åþ㤷¤Ë¤¯¤¯¤Ê¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£2)
·ìÅüÃͤ¬¹â¤¯¤Æ¤â¿¤¯¤ÎÊý¤Ï̵¾É¾õ¤Ç¤¹¤¬¡¢ÊüÃÖ¤¹¤ë¤È´í¸±¤Ç¤¹¡£ÊüÃÖ¤»¤º¡¢¤Ç¤­¤ë»ö¤«¤é¼è¤êÁȤळ¤È¤¬ÂçÀڤǤ¹¡£

¢¡¡þ¤¹¤°¤Ç¤­¤ëIJǢÉÂÂкö

ÅüÇ¢ÉÂÂкö¤Î´ðËܤϡ¢¿©»ö¤ä±¿Æ°¤Ê¤É¤ÎÀ¸³è½¬´·¤Î²þÁ±¤Ç¤¹¡£ÅüǢɤÎÂкö¤ÏŤ¯Â³¤±¤é¤ì¤ë»ö¤¬²¿¤è¤ê¤âÂçÀڤǤ¹¡£ÈîËþ¤òȼ¤¦ÅüǢɤθºÎÌÌÜɸ¤Ï1¥ö·î¤Ç0.5­ÔÄøÅÙ¤¬Ìܰ¤Ǥ¹¡£¤­¤Á¤ó¤È³¤±¤Æ¤¤¤±¤Ð£±Ç¯¤Ç6­Ô¤Î¸ºÎ̤¬´üÂԤǤ­¤Þ¤¹¡£¤Þ¤º°Ê²¼¤Î£³¤Ä¤Î½¬´·¤«¤é»Ï¤á¤Æ¤ß¤Þ¤·¤ç¤¦¡£3)

­¡ÂνŷפËËèÆü¾è¤ë

ÈîËþ¤ÏÅüǢɤÎȯ¾É¤ä°­²½¤Ë·Ò¤¬¤ë¤¿¤á¡¢ÂνŤò¤­¤Á¤ó¤È´ÉÍý¤¹¤ë»ö¤¬·ç¤«¤»¤Þ¤»¤ó¡£¤½¤Î£±Ê⤬ËèÆü¡¢ÂνŷפÇÂνŤòÎ̤ë»ö¤Ç¤¹¡£

ËèÆü¬Äꤹ¤ë¤³¤È¤Ç¡¢¤É¤Î¤è¤¦¤ÊÀ¸³è½¬´·¤ò¤¹¤ë¤ÈÂνŤ¬Áý¤¨¤¿¤ê¡¢¸º¤Ã¤¿¤ê¤¹¤ë¤Î¤«¤¬Ê¬¤«¤Ã¤Æ¤­¤Þ¤¹¡£

­¢Å¬Å٤ʱ¿Æ°¤ò¤¹¤ë

·ò¾ï¿Í¤Ç¤ÏÅü¤Î7³ä°Ê¾å¤¬¹ü³Ê¶Ú¤ÇÍøÍѤµ¤ì¤Æ¤¤¤Þ¤¹¡£°ìÊý¡¢ÅüǢɴµ¼Ô¤Ç¤Ï¹ü³Ê¶Ú¤Ç¤ÎÅü¤ÎÍøÍÑΨ¤¬£µ³äÄøÅÙ¤ËÄã²¼¤·¤Æ¤¤¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£4)

±¿Æ°¤ò¤·¤Æ¶ÚÆù¤òư¤«¤¹¤È¡¢¶ÚÆù¤¬Åü¤ò¼è¤ê¹þ¤à¤¿¤á·ìÅüÃͤ¬²¼¤¬¤ê¤Þ¤¹¡£ ¤Þ¤¿±¿Æ°¤òĹ´ü´Ö³¤±¤Æ¤¤¤ë¤È¡¢¥¤¥ó¥¹¥ê¥ó¤ÎƯ¤­¤¬²þÁ±¤µ¤ì¤Þ¤¹¡£¼ê·Ú¤Ë¤Ç¤­¤ë¤ª¥¹¥¹¥á¤Î±¿Æ°¤ÏÊ⤯¤³¤È¤Ç¤¹¡£

Ϣ³¤Ç¤Ê¤¯¡¢¤³¤ÞÀÚ¤ì¤Ç¤âÎɤ¤¤Î¤Ç¡¢1Æü¤Ë20ʬ¡Á60ʬ¤Û¤É¡¢½µ¤Ë3¡Á5ÆüÊ⤯¤è¤¦¤Ë¤·¤Þ¤·¤ç¤¦¡£Â©¤¬ÃƤàÄøÅ٤ή¤µ¤ÇÊ⤯¤È¤è¤ê¸ú²ÌŪ¤Ç¤¹¡£

­£¿©ÊªÁ¡°Ý¤òÀѶËŪ¤ËÀݼ褹¤ë

¿©ÊªÁ¡°Ý¤Ï¡¢Ä²¤Ë¤¿¤É¤êÃ夯¤ÈIJÊɤòʤ¤¤¡¢¤½¤Î¸å¤Ë¤ä¤Ã¤Æ¤­¤¿Åü¼Á¤ä»é¼Á¤ÎµÛ¼ý¤òÍÞ¤¨¡¢¿©¸å¤Î·ìÅüÃͤξ徺¤ò´Ë¤ä¤«¤Ë¤·¤Æ¤¯¤ì¤Þ¤¹¡£ ¤è¤Ã¤Æ¤´ÈÓ¤ä¥Ñ¥ó¤Ê¤É¤Î¼ç¿©¤ò¿©¤Ù¤ëÁ°¤Ë¿©ÊªÁ¡°Ý¤òÀݼ褹¤ë¤È¸ú²ÌŪ¤Ç¤¹¡£

¼ÂºÝ¤Ë¿©ÊªÁ¡°ÝÀݼèÎ̤ÎÁý²Ã¤¬·ìÅüÃͤÎÊÑÆ°¤ò²þÁ±¤¹¤ë¤«Ä´¤Ù¤¿»î¸³¤Ç¤Ï¥¨¥Í¥ë¥®¡¼Î̤ȱÉÍܥХé¥ó¥¹¤¬Æ±¤¸¤Ç¤â¿©ÊªÁ¡°Ý¤ò¿¤¯Àݼ褷¤¿¥°¥ë¡¼¥×¤ÎÊý¤¬1Æü¤òÄ̤·¤Æ·ìÅüÊÑÆ°¤¬ÌÀ¤é¤«¤ËÄã²¼¤¹¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£5)

¢¡¡þÌô¶É¤Ç·ò¹¯ÁêÃÌ

Ìô¶É¤ÏÌô¤ò¤â¤é¤¦¤È¤³¤í¤À¤È»×¤Ã¤Æ¤¤¤Þ¤»¤ó¤«¡©Ìô¶É¤Ç¤ÏÌô¤ÎÁêÃ̤Ϥâ¤Á¤í¤ó¡¢Ìô°Ê³°¤Î·ò¹¯¤Ë´Ø¤¹¤ëÁêÃ̤â¤Ç¤­¤Þ¤¹¡££²·¿ÅüǢɤϾɾõ¤¬·Ú¾É¤Î¤¦¤Á¤ËÀ¸³è½¬´·¤ò²þÁ±¤¹¤ë¤³¤È¤Ç¥¤¥ó¥¹¥ê¥ó¤äÆâÉþÌô¤¬ÉÔÍפȤʤ뤳¤È¤â¾¯¤Ê¤¯¤¢¤ê¤Þ¤»¤ó¡£Ìô¶É¤ÇÀ¸³è½¬´·¤ÎÁêÃ̤ò¤·¤Æ¤ß¤Þ¤»¤ó¤«¡©


»²¹Í¡Ë
1) ÆüËÜÆâ²Ê³Ø²ñ»ï 2006;95:35-40
2)ÅüǢɥͥåȥ¥¯
https://dm-net.co.jp/seminar/25/
3)¤­¤ç¤¦¤Î·ò¹¯ 2019.8
4)DeFronzo RA,Diabetes,1988;37(6):667-87.
5)N Engl.J Med.,342:1392-1398,2000




¤¤¤«¤¬¤Ç¤·¤¿¤«¡©·ò¹¯¤Ë¤Ä¤¤¤Æ¡¢¤ª¶á¤¯¤Î¥¯¥¹¥ê²°¤µ¤ó¤ËÁêÃ̤·¤Æ¤ß¤Þ¤»¤ó¤«¡©
¢Í
¤³¤Á¤é¤«¤é¡¢¤ª¶á¤¯¤ÎÆüÀìÆ±¤Î¤ªÅ¹¤¬Ãµ¤»¤Þ¤¹¡£

ͯ±ÊÀ½Ìô¤Ï¡ÖÆüÀìÆ±(ÆüËÜÀìÌçÌô¶ÉƱ»Ö²ñ)¡×¤ò±þ±ç¤·¤Æ¤¤¤Þ¤¹